<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=HPA-23</id>
	<title>HPA-23 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=HPA-23"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=HPA-23&amp;action=history"/>
	<updated>2026-04-27T01:50:49Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=HPA-23&amp;diff=5375386&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=HPA-23&amp;diff=5375386&amp;oldid=prev"/>
		<updated>2024-03-08T19:08:39Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;HPA-23&amp;#039;&amp;#039;&amp;#039; is an [[antiviral drug]] that was developed in the 1980s. It is a [[nucleoside analogue]], which means it mimics the structure of the building blocks of [[DNA]] and [[RNA]]. This allows it to interfere with the replication of [[virus|viruses]].&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
HPA-23 was first synthesized in the late 1970s by the [[French National Institute of Health and Medical Research]]. It was initially developed as a potential treatment for [[cancer]], but was later found to have potent antiviral properties. In the 1980s, it was used experimentally to treat patients with [[AIDS]], but was eventually discontinued due to its severe side effects.&lt;br /&gt;
&lt;br /&gt;
== Mechanism of Action ==&lt;br /&gt;
HPA-23 works by inhibiting the [[reverse transcriptase]] enzyme, which is crucial for the replication of [[retrovirus|retroviruses]] like [[HIV]]. By blocking this enzyme, HPA-23 prevents the virus from making copies of itself.&lt;br /&gt;
&lt;br /&gt;
== Clinical Use ==&lt;br /&gt;
Despite its initial promise, HPA-23 was never widely used in clinical practice. Its severe side effects, which include [[kidney damage]], [[liver damage]], and [[anemia]], made it too risky for most patients. However, it was used experimentically in a small number of AIDS patients in the 1980s.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
The most common side effects of HPA-23 are [[nausea]], [[vomiting]], and [[diarrhea]]. More serious side effects include kidney damage, liver damage, and anemia. These side effects are often severe enough to require discontinuation of the drug.&lt;br /&gt;
&lt;br /&gt;
== See Also ==&lt;br /&gt;
* [[Antiviral drug]]&lt;br /&gt;
* [[Nucleoside analogue]]&lt;br /&gt;
* [[Reverse transcriptase]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Antiviral drugs]]&lt;br /&gt;
[[Category:Nucleoside analogues]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{pharmacology-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>